Korean J Med.  2005 Nov;69(5):545-548.

A case of nizatidine induced cholestatic hepatitis

Affiliations
  • 1Department of Internal Medicine, Asan Medicine Center, University of Ulsan College of Medicine, Seoul, Korea. limys@amc.seoul.kr

Abstract

Histamine H2-receptor antagonists are commonly used in many clinical conditions, and their hepatotoxicity has been reported occasionally.However, cholestatic hepatitis induced by nizatidine is very rare. Here, we report a young female patient with severe cholestatic hepatitis associated with nizatidine use. She had taken nizatidine to manage asymptomatic reflux laryngitis by an otonasolaryngology doctorfor about 20 days. After about 15 days of nizatidine administration, jaundice developed and continued for more than2 months withmaximal serum total bilirubin reaching 17.5 mg/dL, in spite of the discontinuation of medication. Liver specimen obtained by needle biopsy revealed severe centrilobular cholestatic hepatitis. Her liver function improved slowly and serum total bilirubin decreased down to 1.7 mg/dL after months later from the development of jaundice. As far as our knowledge, this is the second case of nizatidine- induced cholestatic hepatitis reported in the literature.

Keyword

Nizatidine; Cholestasis; Hepatitis

MeSH Terms

Bilirubin
Biopsy, Needle
Cholestasis
Female
Hepatitis*
Histamine
Humans
Jaundice
Laryngitis
Liver
Nizatidine*
Bilirubin
Histamine
Nizatidine
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr